CIK: 0001388551 · Show all filings
Period: Q4 2012 (Next →)
Filing Date: Oct 4, 2013
Total Value ($000): $232,688 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | SYNTA PHARMACEUTICALS CORP | 20,527,277 | $185,156 | 79.6% | $9.02 | — | COM | 87162T206 |
| — | VIVUS INC | 2,838,000 | $38,086 | 16.4% | $13.42 | — | COM | 928551100 |
| — | HALLMARK FINL SVCS INC EC | 1,005,981 | $9,446 | 4.1% | $9.39 | — | COM NEW | 40624Q203 |